Table 2.
Baseline ongoing activity in animals treated with vehicle, FAc, or L-AA.
Aδ | C | Combined population | |
---|---|---|---|
Control | (n = 21); 0.05 (0.23) | (n = 32); 0.77 (1.4) | 0.16 (1.18) |
FAc | (n = 10); 0.08 (0.50) | (n = 8); 0.88 (1.83) | 0.16 (1.23) |
L-AA | (n = 7); 0.1 (0.70) | (n = 8); 0.85 (1.18) | 0.77 (0.98) |
Data are expressed as median (IQR). N represent the number of afferents tested (1 afferent/animal). Ongoing activity (in spikes/sec) is based on data collected for at least 45 minutes before CSD. Group differences were analyzed using 2-tailed Kruskal–Wallis test and were not significant (P > 0.05) for the population tested.
FAc, fluoroacetate; L-AA, L-α-aminoadipate.